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Score to predict outcome in elective open
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Objectives: Selecting patients based on their risk profiles could improve the outcome after elective surgery of an
abdominal aortic aneurysm (AAA). The Glasgow Aneurysm Score (GAS) is a scoring system developed to determine such
risk profiles. In other settings, the GAS has proved to have a predictive value for the postoperative outcome. The aim of
this study was to investigate whether the GAS was also valid for the patients in our hospital and to examine risk factors
with a possible predictive value for postoperative mortality and morbidity.
Methods: We performed a retrospective cohort study in a university hospital. The medical records of 229 patients who
underwent open elective repair for an AAA in the period 1994 to 2003 were retrospectively analyzed to assess the GAS
and to determine which of the examined risk factors had a predictive value for the prognosis.
Results: Five patients (2.2%) died after surgery and 30 (13.1%) had a major complication. The GAS was predictive for
postoperative death (P  .021; sensitivity, 1.00; 95% confidence interval [CI], 0.52 to 1.00; specificity, 0.67; 95% CI,
0.61 to 0.73) and also for major morbidity (P  .029; sensitivity, 0.63; 95% CI, 0.46 to 0.78; specificity, 0.70; 95% CI,
0.64 to 0.76). The positive predictive value (mortality, 0.06; morbidity, 0.24) and the positive likelihood ratio
(mortality, 3.07; morbidity, 2.14) were low, however. The best cutoff value for the GAS was determined at 77. All the
deceased patients (100%) and 63.3% of those who had a major complication had a risk score of>77. Of all examined risk
factors, suprarenal clamping during surgery was predictive of in-hospital mortality (8.3%, P  .017). For major
morbidity, three risk factors, all of which are components of the GAS, were predictive: age (P  .046), cardiac disease
(P  .032), and renal disease (P  .041).
Conclusions: The Glasgow Aneurysm Score has a predictive value for outcome after open elective AAA repair. Because
of its relatively low positive predictive value for death and major morbidity, the GAS is of limited value in clinical
decision-making for the individual high-risk patient. In some particular cases, however, the GAS can be a useful tool,
especially for low-risk patients because it has good negative predictive value for this group. Suprarenal clamping was
found to be a risk factor for postoperative death. (J Vasc Surg 2006;44:712-6.)Elective abdominal aortic aneurysm (AAA) surgery is
still accompanied with many risks that result in considerable
postoperative mortality and morbidity. Overall, the mortal-
ity rate varies from about 2% to 8%1-3 and increases up to 8%
to 12% in patients with serious comorbidity.4,5 Respiratory,
cardiac, renal, and intestinal complications, among others,
occur in 14% to 40% of the patients,1,4 depending on the
patient’s risk profile and the kind of treatment (ie, open
or endovascular surgery). Cardiac complications, especially
myocardial infarction, are the most frequent causes of
death, but respiratory, renal, and cerebral complications
often have a lethal outcome as well.1,2,6,7
This risk profile is crucial in the patient’s preoperative
assessment, because it predicts perioperative complica-
tions and might help the patient and the surgeon to make
a choice for surgical or conservative treatment. Samy
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712et al8,9 derived and validated a simple scoring system, the
Glasgow Aneurysm Score (GAS), for risk stratification of
patients undergoing elective open repair of an AAA. The
GAS represents a numerical score for the patient’s pre-
operative medical condition and thereby is a measure for
the patient’s risk profile to predict outcome after sur-
gery.1,8,9 The main goal of this scoring system is to divide
patients into a low-risk or a high-risk group. According to
the GAS, the high-risk group, who might be unsuitable for
operation, consists of patients with a risk score of 79
points.1,4
The validity of the GAS has been tested in two Finnish
hospitals. The investigators stated that the GAS is a good
predictor of postoperative mortality and morbidity. The
external validity of the GAS is insufficiently studied, how-
ever, which is a reason that the scoring system has not yet
been widely adopted.
The aim of this article is (1) to further study the external
validity of the GAS and to assess its usefulness to simplify
and improve the selection of patients with an infrarenal or
juxtarenal AAA for elective open surgery and (2) to exam-
ine whether other preoperative risk factors not defined in
the GAS have a predictive value for postoperative mortality
and morbidity.
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Glasgow Aneurysm Score and other variables. The
GAS is calculated using the formula: risk score  age in
years  (7 points for myocardial disease)  (10 points for
cerebrovascular disease)  (14 points for renal disease).
Myocardial disease refers to previously documented myo-
cardial infarction or ongoing angina pectoris, or both.
Cerebrovascular disease comprises all grades of stroke in-
cluding transient ischemic attack. Renal disease is defined as
a serum level of urea 20 mmol/L, a serum level of
creatinine150mol/L at the time of surgery, a history of
chronic or acute renal failure, or a combination of these.1
In addition to the GAS, we included several other
variables that might also predict prognosis after elective
surgery (Table I). Furthermore, the risk factors of age,
cardiac disease, cerebrovascular disease, and renal disease
are components of the GAS and have also been analyzed
individually to have a better understanding of the GAS.
End points. Two end points were chosen: in-hospital
mortality and major morbidity. We defined major morbid-
ity as postoperative complications that are irreversible or
need admittance at the intensive care unit or reoperation
(Table II).
Patients. A retrospective cohort study was performed.
Patients who had elective open repair of an infrarenal or
juxtarenal aneurysm of the aorta in the period 1994 to
Table I. Demographic characteristics in 229 patients
(1994 to 2003)
Examined risk factors
GAS
component N %
Sex, male 193 84.3
Age at operation (yrs)
(range) Yes 69 (23-89)
ASA classification
I 4 1.7
II 57 24.9
III 138 60.3
IV 30 13.1
Clamp
Infrarenal 193 84.3
Suprarenal 36 15.7
No -blockers (peri-op) 132 57.6
Cardiac disease Yes 83 36.2
Cerebrovascular disease Yes 30 13.1
Renal disease Yes 14 6.1
Diabetes mellitus 17 7.4
COPD 28 12.2
Mean BMI (kg/m2)
(range) 25.6 (15.9-36.4)
History of smoking 206 90
GAS in points, mean
(range) 73 (23-112)
Outcome end points
In-hospital mortality 5 2.2
Major morbidity 30 13.1
GAS, Glasgow Aneurysm Score; ASA, American Society of Anesthesiolo-
gists; COPD, chronic obstructive pulmonary disease; BMI, body mass index.2003 in the Academic Medical Center in Amsterdam wereanalyzed. All information necessary was retrieved from the
electronic hospital database and patient charts.
Statistical analysis. Statistical analysis was performed
using SPSS 11.5 (SPSS, Inc, Chicago, Ill) for Windows
(Microsoft Corp, Redmond, Wash). Logistic regression
analysis was performed. The Fisher’s exact test was used for
univariable analysis of categoric data. The Student’s t test
was used for univariable analysis of continuous data. For a
univariable analysis of K independent samples (2 sub-
groups; eg, American Society of Anesthesiologists classifi-
cation), the nonparametric Kruskal-Wallis test was used.
After univariable analysis, only those variables with
(borderline) significance (P  .10) were included in the
regression models. In the multivariable analysis variables
with P  .05 were considered statistically significant. Re-
ceiver operating characteristic (ROC) analysis was used to
evaluate the adequacy of the GAS in predicting postopera-
tive in-hospital mortality and major morbidity and to iden-
tify the best cutoff values.
RESULTS
During the study period, 229 consecutive patients un-
derwent elective open repair of an infrarenal or juxtarenal
aneurysm. All were included in this study. The demo-
graphic characteristics of this population are shown in
Table I. Not included were 68 patients with endovascular
repair.
In-hospital mortality. Five patients (2.2%; 95% con-
fidence interval [CI], 0.7% to 5.0%) died after surgery
(Table I). With univariable analysis, four factors had a
possible predicting value (Table III). After multivariable
analysis, the GAS (P  .021), suprarenal clamping (P 
.017), and a history of smoking (P  .026) proved to be
independent predictors of death (Table IV). Among the
individual components of the GAS (eg, age), no significant
differences could be found.
Analysis of the ROC curve (Fig 1) showed that the GAS
had an area under the curve of 0.839 for predicting the
postoperative in-hospital mortality. According to the ROC
Table II. Major morbidity
Major morbidity Frequency n (%)
Reoperation
For peripheral ischemia 9 (3.9)
For bowel ischemia 6 (2.6)
Renal failure requiring dialysis 3 (1.3)
Pulmonary embolism 0 (0.0)
Clinically relevant myocardial infarction 6 (2.6)
Cardiac arrhythmia requiring resuscitation 4 (1.7)
Stroke 0 (0.0)
ARDS 1 (0.4)
LV failure requiring ICU readmittance 5 (2.2)
Trash-foot 3 (1.3)
Infection of prosthesis 1 (0.4)
ARDS, Adult respiratory distress syndrome; ICU, intensive care unit;
LV, left ventricular.curve, the best cutoff point for the GAS was 76.5. At this
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mum (sensitivity, 100%; specificity, 67%). Further charac-
teristics of this test can be found in Table V.
Major morbidity. Thirty patients (13.1%) had one or
more major complications (Table I). With univariable anal-
ysis, four factors (Table III) had a possible predicting value.
Multivariable analysis (Table IV) showed the GAS (P 
.029) was a predicting scoring system. Furthermore, three
of its four individual components—age (P .046), cardiac
disease (P .032), and renal disease (P .041)—were also
independent predictors of major morbidity.
The GAS had an area under the curve of 0.661 (Fig 2)
in predicting postoperative major morbidity after elec-
tive AAA repair. The best cutoff value for the GAS was
76.5 (sensitivity, 63%; specificity, 70%). Patients with a risk
score of 77 points belonged to the high-risk group. In
Table V, the characteristics of the test and the 95% CIs are
summarized.
DISCUSSION
Our study showed the GAS had a predictive value for
prognosis after elective open AAA repair. Suprarenal clamp-
ing also was predictive for mortality. Three components of
the GAS, namely age, cardiac disease and renal disease, also
independently proved to have a predictive value for major
Table III. Univariable analysis: possible predicting factors
Examined variables Mortality (P) RR*
GAS 0.027
Age at time of operation 0.163
Cardiac disease 0.059 7.0 (
Cerebrovascular disease 0.508 1.7 (
Renal disease 0.273 3.8 (
Sex 0.578 0.8 (
ASA classification 0.794
Body mass index 0.389
Suprarenal clamp 0.029 8.3 (
Diabetes mellitus 1.000 0.0 (
COPD 1.000 0.0 (
No -blockers (peri-op) 0.165 0.2 (
History of smoking 0.080 0.2 (
RR, Risk ratios; CI, confidence intervals; GAS, Glasgow Aneurysm Score; A
disease; NA, not accessible.
*The risk ratios are given for the dichotomous variables.
Table IV. Multivariable analysis: predicting factors for
in-hospital mortality and major morbidity
Predicting factors P RR (95% CI)
In-hospital mortality
Suprarenal clamp .017 10.0 (1.54-84.6)
History of smoking .026 0.09 (0.01-0.74)
Major morbidity
Glasgow Aneurysm Score .029 1.3 (1.09-1.43)
Age at time of operation .046 1.2 (1.01-1.38)
Cardiac disease .032 5.0 (1.14-16.7)
Renal disease .041 2.8 (1.26-37.9)morbidity. The end points in our study were mortality andmajor morbidity (Table I and II). Minor morbidity was not
chosen as an end point because the GAS was mainly devel-
oped to prevent more severe complications as they have a
higher negative impact on patients’ lives.
According to our study results, patients are divided into
low-risk and high-risk groups with a cutoff point to differ-
entiate at a GAS of 77 (Table VI). This fairly corresponds
with the original study of Biancari4 that classified patients
with a score of 79 points in the high-risk group. As such,
the GAS is shown to be externally valid; however, the GAS
has limitations for clinical decision-making. Striking are the
low positive predictive value and positive likelihood ratio,
old) for the in-hospital mortality and major morbidity
CI) Major morbidity (P) RR* (95% CI)
0.011
0.038
61.9) 0.043 2.0 (1.03-3.91)
14.3) 0.775 0.7 (0.24-2.28)
32.1) 0.094 2.4 (1.08-5.94)
6.52) 0.278 0.5 (0.24-1.35)
0.722
0.342
46.4) 0.278 0.6 (0.28-1.32)
1.000 0.9 (0.23-3.43)
0.548 0.5 (0.13-2.04)
1.62) 0.693 0.8 (0.43-1.64)
0.95) 0.516 0.7 (0.28-1.90)
erican Society of Anesthesiologists; COPD, chronic obstructive pulmonary
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Fig 1. According to the receiver operating characteristic (ROC)
curve, the best cutoff point is for the Glasgow Aneurysm Score
(GAS) for mortality is 76.5.(in b
(95%
0.80-
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SA, Ammeaning that the system is not very helpful for the individ-
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not contribute to a better test because it will lead to more
false-negatives and only slightly improves the positive like-
lihood ratio.
On the other hand, the GAS turned out to have a good
negative predictive value and the negative likelihood ratio is
also acceptable, meaning that patients with a large AAA
who belong to the low-risk group are not likely to die or
develop a major complication if open AAA repair is done.
Other studies draw similar conclusions: when patients have
few or no risk factors the postoperative mortality after
elective repair is low, from 2.7% to 3.0% vs 7.8% to 9.0% in
patients with more risk factors.4,5
Nesi et al10 also describe a low positive predictive value
and the high negative predictive value of this scoring system
for postoperative mortality and morbidity. Their study com-
Table V. Glasgow Aneurysm Score characteristics for
in-hospital mortality and major morbidity*
Test characteristics cutoff
point: 76.5
In-hospital
mortality value
(95% CI)
Major
morbidity value
(95% CI)
Sensitivity 1.00 (0.52-1.00) 0.63 (0.46-0.78)
Specificity 0.67 (0.61-0.73) 0.70 (0.64-0.76)
Positive predictive value 0.06 (0.03-0.15) 0.24 (0.16-0.35)
Negative predictive value 1.00 (0.97-1.00) 0.93 (0.87-0.96)
Positive likelihood ratio 3.07 (2.07-3.81) 2.14 (1.51-3.02)
Negative likelihood ratio 0.00 (0.00-0.76) 0.52 (0.32-0.84)
CI, Confidence interval.
*Patients with 77 points are categorized in the high-risk group.
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Fig 2. According to the receiver operating characteristic (ROC)
curve, the best cutoff point for the Glasgow Aneurysm Score (GAS)
for morbidity is 76.5.pared the GAS with four other scoring systems for the predic-tion of outcome and concluded that the GAS was the most
useful for a quick risk stratification during initial patient
consultations and is the easiest to use in routine clinical
practice. Samy et al9 also recommended use of the GAS in
clinical practice because the test meets the criteria for a
useful surgical score in that the test is simple, easy to
calculate, and does not require an experienced physician.
These two studies described the pros of the test but not the
likelihood ratios and predictive values in this context.
The GAS also has some other limitations: it does not
account for the protective effects of coronary artery bypass
grafting or percutaneous transluminal coronary angio-
plasty for cardiac disease, carotid endarterectomy for cere-
brovascular disease, and the use of medications in general.
Nonetheless, the GAS was examined in several European
studies1,4,10 and all emphasized its validity in predicting
outcome after open repair. As for endovascular repair, the
Endovascular Aneurysm Repair 2 (EVAR2) trial showed
that this type of surgery is accompanied with a high mor-
tality and morbidity rate in high-risk patients and has no
survival benefit compared with no intervention.11 There-
fore, assessment of the validity of the GAS for such patients
can be useful. A recent report of Biancari et al12 made clear
that the GAS also predicts the postoperative mortality after
endovascular repair.
From the other 12 examined parameters, suprarenal
clamping was a predictor of postoperative mortality
(Table VII). Green et al13 also concluded that suprare-
nal clamping was associated with a higher mortality rate.
El-Sabrout et al14 mentioned a comparable percentage for
mortality after suprarenal clamping (5.7%), but concluded
that there was no significant difference between infrarenal
and suprarenal clamping because some variables (eg, age)
differed among the examined groups in their study. Other
reports showed an insignificant increase in the mortality
Table VI. Prognosis in the two risk groups*
Risk group (n)
In-hospital mortality
n (%)
Major morbidity
n (%)
Low-risk, 151 0 (0.0) 11 (7.3)
High-risk, 78 5 (6.4) 19 (24.4)
*Patients with 77 points belong to the high-risk group.
Table VII. Patients with suprarenal clamping have a
significant higher chance of dying, those in the smoking
group have not
Risk factor Total N Postoperative death N (%)
Clamping
Infrarenal 193 2 (1.0)
Suprarenal 36 3 (8.3)
History of smoking
No 23 2 (8.7)
Yes 206 3 (1.5)rate and stated that suprarenal clamping could be per-
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examined this possible risk factor, including the current
one, included a small number of patients (n  60) with
suprarenal clamping.
Our study found a history of smoking was also signifi-
cant after multivariable analysis for postoperative mortality
(Table 4). The mortality rate was lower in the smoking
group (Table VII), however, which would assign a protec-
tive effect for smoking. This is not conceivable and is merely
a result of a high percentage of smokers (90.0%) and a low
number of events (5 deaths, 2.2%), as shown in Table I.
Besides, we could not differentiate in the quantity and
duration characteristics of the smoking habits of the pa-
tients with our data, which influenced the results. This is
one of the limitations of this study. Brady et al5 examined a
population of 820 patients and concluded that smoking
was not associated with a poorer outcome regarding mor-
tality. Another limitation of our study remains the relatively
small number of patients included and the retrospective
design.
As for major morbidity, the factors of age, cardiac
disease, and renal disease—three of the four components of
the GAS—independently proved to have a predictive value
(Table IV). Thus, the significance of the GAS cannot
exclusively be ascribed to one separate parameter: it is, with
exception of the cerebrovascular component, formed by all.
CONCLUSION
The GAS has been documented to have external valid-
ity. The scoring system is particularly useful in low-risk
patients because of its negative predictive value. These
patients have a good prognosis and this can be communi-
cated to the patient. It also helps to identify high-risk
patients, although some limitations remain with the indi-
vidual risk assessment as a result of the low predictive value.
Because the test is not useful for clinical decision-making
for every individual patient, we do not recommend that
patients be selected for elective surgery solely on the GAS.
The usefulness of the GAS is thus mainly as an additional
tool to help the surgeon to reach a decision about patients
who have a large aneurysm but who also have a complicated
risk profile. We have incorporated the calculation of the
GAS score in our electronic patient chart system and con-
sider its calculation helpful in the risk communication with
the patient.
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